|
3.4 Chimioprévention
|
|
|
Can Topical Drugs Help Prevent Breast Cancer? [NCI]
|
|
|
|
|
|
To
explore alternatives to oral tamoxifen that might have fewer side
effects, researchers are testing a topical form of the drug in two
clinical trials. These randomized placebo-controlled studies are
evaluating a gel formulation of tamoxifen called 4-hydroxytamoxifen
(4-OHT) that women apply directly to the breasts.
|
|
|
|
|
|
|
4.10 Dép., diag. & prono. - FDA, EMA, NICE,...
|
|
|
|
4.10 Dép., diag. & prono. - Poumon
|
|
|
|
4.12 Biopsies liquides
|
|
|
|
Scientists develop 10-minute universal cancer test [The Guardian]
|
|
|
|
|
|
The
test was made possible by the Queensland team’s discovery that cancer
DNA and normal DNA stick to metal surfaces in markedly different ways.
This allowed them to develop a test that distinguishes between healthy
cells and cancerous ones, even from the tiny traces of DNA that find
their way into the bloodstream.
|
|
|
|
|
|
|
|
5. Traitements
|
|
|
|
5.12.5 Immunothérapies - Pharma
|
|
|
|
|
5.2 Pharma
|
|
|
|
5.7 SABCS
|
|
|
SWOG Shares Trio of Studies in San Antonio [SWOG]
|
|
|
|
|
|
"In
these three studies, SWOG researchers share results that better define
subsets of patients and tumors with respect to treatment response,
toxicities, and cancer recurrence. These are strong examples of our
work.”
|
|
|
|
|
|
|
5.8 ASH
|
|
|
ASH Highlights for Tuesday, December 4, 2018 [OBR]
|
|
|
|
|
|
Thierry
Facon, Service des Maladies du Sang, Hôpital Claude Huriez, Lille,
France, presented the pre-specified interim analysis of the MAIA study, a
phase 3 trial evaluating daratumumab plus lenalidomide and low dose
dexamethasone (D-Rd) versus Rd in patients with transplant-ineligible,
newly diagnosed multiple myeloma.
|
|
|
|
|
|
|
5.8.1 ASH - Communiqués
|
|
|
|
5.8.2 ASH - Pharma
|
|
|
|
5.8.3 ASH - Divers
|
|
|
|
|
5.8.4 ASH - CAR T
|
|
|
|
|
|
5.8.5 ASH - Myélome multiple
|
|
|
|
|
|
5.8.6 ASH - Leucémies
|
|
|
|
|
|
|
|
6.1 Observation
|
|
|
|
6.6 Publications
|
|
|